Jens is the Founder and CEO of Insempra with its headquarters in Munich, Germany. Insempra is a synthetic biology company which scales biotechnological processes to build ingredients with significantly less energy requirements and waste produced, while eradicating the need for petrochemical or natural extracted ingredients. The company is bridging the gap between leading R&D-focused organizations and brands/OEMS to scale climate focused innovation. The first products in the market are very successful. Jens was heading AMSilk as CEO before. AMSilk is the world’s first industrial supplier of vegan silk biopolymers. AMSilk has announced collaborations and partnerships with world leading brands like Adidas, OMEGA, Mercedes-Benz and Airbus. Jens was responsible for the divestment of the cosmetics division of AMSilk to specialty chemicals giant Givaudan in 2019 serving btob customers like Natura and The Body Shop. Before joining AMSilk, Jens worked for Evonik Industries. In 2011 Evonik acquired Jens’ last companies nanoresins AG and Hanse Chemie AG. Prior, Jens was a member of the Board of Directors of the investment firm Mulligan BioCapital. Mulligan invested in medical technology, biotech and high-tech enterprises in the US and Europe. Before joining Mulligan, he was with Fresenius AG, Bad Homburg where he headed subsidiaries as CEO or CFO.

‍